Best Daiichi Sankyo Podcasts (2024)

1
Breaking Biotech Barriers: Avidity President & CEO Sarah Boyce on RNA’s Next Frontier 35:08

1h ago35:08

35:08

Synopsis: In this episode, host Rahul Chaturvedi interviews Sarah Boyce, President & CEO of Avidity Biosciences, as she shares her dynamic journey from big pharma to leading groundbreaking advancements in RNA therapeutics. Sarah delves into overcoming drug delivery challenges, the transformative potential of genetic medicine, and Avidity’s mission …

1
Mehrnaz Campell in conversation with Chiara Bolgnini from Roche 1:01:31

9h ago1:01:31

1:01:31

After a brief break for summer, the Digital Transformation Series is back and I've already lined up several months of interviewees! 🎙️ On the 22nd August, l chatted with the amazing Chiara Bolgnini. Chiara is a Senior Marketing and Commercial Leader with 20 years of experience. She has worked for 14 years in life science companies in senior global …

1
Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity 31:40

16d ago31:40

31:40

Synopsis:Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as he unveils the groundbreaking ways AI is revolutionizing drug discovery. Fabrice will take you behind the scenes of Cellarity’s trailblazing approach, revealing how their pioneering technology is accel…

1
Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam 24:38

29d ago24:38

24:38

Synopsis:Get ready for an insightful conversation as host Rahul Chaturvedi connects with John Alam, CEO of CervoMed, to uncover the revolutionary advancements transforming dementia treatment, with a spotlight on Dementia with Lewy Bodies (DLB). John shares his remarkable journey from practicing medicine to leading cutting-edge biotech innovations, …

1
From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation 30:51

1M ago30:51

30:51

Synopsis:Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, appears on this insightful episode of Biotech 2050 with host Rahul Chaturvedi. Renée shares her unconventional journey from investment banking to biotech leadership, underscoring the crucial role of capital markets and regulatory strategies. The discussion explores the unique challenge…

1
Autoimmune Innovations: Insights from Marshall Fordyce, Founder & CEO, Vera Therapeutics on Biotech 32:50

1M ago32:50

32:50

Synopsis: In this engaging episode, host, Rahul Chaturvedi welcomes Marshall Fordyce, Founder and CEO of Vera Therapeutics, to discuss his transformative journey from physician to biotech entrepreneur. Marshall shares the story behind Vera Therapeutics' strategic pivot to focus on IG nephropathy and their development of atacicept, a promising B-cel…

1
Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx 50:25

2M ago50:25

50:25

Synopsis:Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. S…

1
Biotech Breakthroughs: Jeb Keiper, CEO of Nimbus Therapeutics, Discusses Their Innovative Journey 35:03

2M ago35:03

35:03

Synopsis:Dive into this episode of Biotech 2050 where host Rahul Chaturvedi interviews Jeb Keiper, CEO of Nimbus Therapeutics. Discover Jeb's fascinating journey from MIT chemist to industry leader, and the unique strategies that have driven Nimbus's success. Jeb discusses the evolution of biotech financing, the importance of taking bold risks, and…

1
Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development 36:55

2M ago36:55

36:55

Synopsis:Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development. Sujal shares his transition from tech to biotech, the formation of Nautilus with Parag Mallick, and their revolutionary approach using multi-affinity probes. The conversation highlights the importance…

1
Mehrnaz Campbell in conversation with Emma Vitalini from Amgen 56:48

2M ago56:48

56:48

Mehrnaz Campbell chats with Emma Vitalini, Head of Global Medical Digital Strategy at Amgen. Emma has focused her recent attention and development on the strategic build and deployment of new and evolving technologies.By Mehrnaz Campbell

1
Exploring Neuroscience, Psychiatry, & Rare Diseases, Bruce Leuchter, President & CEO, Neurvati 51:22

3M ago51:22

51:22

Synopsis: In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of Vibe Bio, speaks with Dr. Bruce Leuchter, President and CEO of Neurvati Neuroscience. They discuss capital markets, neurology, psychiatry, and Neurvati's work in ultra-rare diseases. Dr. Leuchter shares his journey from clinical training to leadership at Neurvati. The …

1
Transformative Oncology Innovations, Ken Keller, President & CEO, Daiichi Sankyo, Inc. 28:18

3M ago28:18

28:18

Synopsis: In this episode of BioTech 2050, Ken Keller, President and CEO of Daiichi Sankyo, Inc. provides an in-depth look into the company's transformation from a cardiovascular-focused organization to a leader in oncology. He discusses the groundbreaking advancements in antibody-drug conjugates (ADCs), particularly highlighting the success of the…

1
Strategic Leadership and Autoimmune Breakthroughs, Praveen Tipimeni, CEO 34:03

4M ago34:03

34:03

Synopsis: In this episode of Biotech2050, Praveen Tipirneni, CEO of Morphic Therapeutics, shares insights on Morphic’s strategic IPO, the rising interest in autoimmune treatments, the journey of their alpha 4 beta 7 program, and maintaining a conservative yet opportunistic approach in biotech. He also discusses the importance of building a strong t…

1
Innovative Approaches to Cancer Therapies, Robert Ang, President and CEO 30:09

4M ago30:09

30:09

Synopsis: In this episode of BioTech 2050, Robert Ang, CEO of Vor Bio, shares insights on the current state of cancer therapies and next-gen modalities. He discusses Vor Bio's work on shielded stem cell transplants and CAR T-cell therapies targeting hematologic malignancies like AML and MDS. Robert also talks about his experience serving on boards …

1
Tech-Biotech Convergence, Growth, and Global Lessons, Vik Bajaj, Co-founder and CEO 31:05

5M ago31:05

31:05

Synopsis: In this episode of Biotech2050, Vik Bajaj, Co-founder and CEO of Foresite Labs, delves into the convergence of tech and biotech, hyper-growth phases in biotech companies, changes in finance and capital markets, and lessons from global healthcare systems, particularly the UK. He highlights the transformative potential of technology in biot…

1
Advancing and Revolutionizing Sickle Cell Treatment, Ted Love, Chair and BOD 27:00

5M ago27:00

27:00

Synopsis: In this episode of Biotech2050, Dr. Ted Love, former CEO of Global Blood Therapeutics and Current Chairman of BIO, shares insights on sickle cell breakthroughs, transitioning from academia to research, navigating a tight funding environment, and protecting an innovative ecosystem to benefit patients.Biography:Dr. Ted Love is the chair of …

1
Mehrnaz Campbell in comversation with Amish Patel from APC 57:55

5M ago57:55

57:55

For our next Digital Transformation Series podcast, Mehrnaz Campbell welcomes Amish Patel, a marketing consultant who aims to simplify pharma marketing in today’s noisy world of shiny things. He is the founder of APC, a marketing consultancy that helps pharma companies create and execute effective engagement strategies while building in-house marke…

1
Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics 31:57

6M ago31:57

31:57

Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominent figure in the biotech industry who co-founded Structure Therapeutics. Ray's extensive experience and pivotal role in advancing structure-based drug discovery make him a compelling guest for biotech e…

1
Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics 27:55

6M ago27:55

27:55

Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in the biotech industry. His deep involvement in the pharmaceutical and biopharmaceutical sector has shaped his strategic approach to leadership and business management. Scott emphasizes the importance of…

1
Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma 50:36

6M ago50:36

50:36

Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the biotech industry and the development of peptide-based therapeutics. Dr. Mammen's extensive career trajectory, from academia to leading pharmaceutical organizations, provides a comprehensive understanding …

1
Mehrnaz Campbell in conversation with Dario Safaric from NEXT Pharma 56:39

6M ago56:39

56:39

Mehrnaz Campbell talks to Dario Safaric as part of my Digital Transformation Series. Dario, in addition to running the NEXT Pharma Summit events, is the VP of Sales and Marketing at Media-Soft. They operate in over 40 countries and it's his responsibility for creating and running global marketing initiatives. He's organised more than 25 events in 1…

1
The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks 40:37

6M ago40:37

40:37

Synopsis: In the recent episode of Biotech2050, Ken Galbraith, CEO of Zymeworks, shares profound insights into the biotech industry, leadership, and the complexities of developing innovative treatments for challenging cancers. Galbraith's accidental entry into biotech in 1987, despite lacking prior experience, led to his pivotal role in establishin…

1
Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis 36:41

7M ago36:41

36:41

Synopsis: In this episode of Biotech2050, host Alok Tayi engages in a profound conversation with Craig Chambliss, CEO and co-founder of Neurellis, delving into their strategic advancements in precision therapies for CNS diseases. Chambliss shares his journey, highlighting his finance and accounting background and pivotal roles in pharmaceutical com…

1
Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics 23:07

7M ago23:07

23:07

Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical background to leading innovative gene therapy companies, highlighting the importance of cross-disciplinary expertise in driving biotech advancements. His insights into the gene therapy landscape and the…

1
Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge 26:45

7M ago26:45

26:45

Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving landscape of aging biology and the innovative approach BioAge is taking to identify therapeutic targets. Kristen's background in aging biology, genetics, and statistics underscores her expertise in the fiel…

1
Merhnaz Campbell in conversation with Patrick Markt from Daiichi Sankyo Europe GmbH 56:40

7M ago56:40

56:40

Mehrnaz Campbell talks to Patrick Markt-Niederreiter, a strategic professional with a passion for customer experience, digital innovation, and agile transformation. Currently serving as the Vice President of Digital Excellence at Daiichi Sankyo Europe GmbH, Patrick is dedicated to driving seamless and convenient end-to-end customer experiences for …

1
The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion 39:42

7M ago39:42

39:42

Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of adaptability and diverse partnerships in driving innovation. Gibson's journey from pursuing an MD-PhD program with a focus on merging engineering and me…

1
Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group 46:09

8M ago46:09

46:09

Synopsis: Christian Angermayer, a prominent investor and entrepreneur in the biotech industry, shares valuable insights in the Biotech2050 podcast, shedding light on the challenges and opportunities within the sector. Drawing from his extensive experience, Angermayer emphasizes the importance of making biotech more accessible to a broader audience …

1
Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT 33:34

8M ago33:34

33:34

Synopsis: In this episode of the Biotech2050 podcast, David Kirn, CEO of 4D Molecular Therapeutics, shares invaluable insights for aspiring entrepreneurs in the biotech industry. Kirn discusses the development of his company's platform that integrates gene therapy and directed evolution to create innovative treatments for genetic diseases. By utili…

1
Mehrnaz Campbell in conversation with Erasmus Holm, Director of Pharma & Commercial Operations, MSD Netherlands 49:11

8M ago49:11

49:11

Merhnaz Campbell interviews Erasmus Holm, Director of Pharma & Commercial Operations at MSD Netherlands, for the final Digital Transformation Series 2023. Erasmus is a Sales and Marketing Strategist who partners with teams and colleagues to transform and grow business, making sure all along that B2B does not mean Boring 2 Boring!…

1
Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics 25:30

8M ago25:30

25:30

Synopsis:In this episode of the Biotech2050 podcast, David Esposito, CEO of ONL Therapeutics, provides valuable insights into the challenges and opportunities in the field of ophthalmology. Esposito's extensive career journey, from the United States Military Academy to leading ONL Therapeutics, underscores his deep understanding of the industry. He…

1
Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics 26:10

9M ago26:10

26:10

Synopsis: In this episode of the Biotech2050 podcast, Jak Knowles, co-founder of Affini-T Therapeutics, shares valuable insights into the challenges faced by bootstrapped biotech companies and the significance of venture capital in the industry. Knowles discusses the importance of finding key partners and securing intellectual property early on, sh…

1
A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology 20:12

10M ago20:12

20:12

Synopsis: Sean Bohen, M.D., Ph.D., is the President and CEO of Olema Oncology, a biopharmaceutical company developing innovative targeted therapies for women’s cancers. We’re excited to welcome Sean back to the podcast – he last appeared on episode 130 in late 2022. Sean provides an update on all the exciting things that have happened at Olema sinc…

1
The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology 33:25

10M ago33:25

33:25

Synopsis: Troy Wilson, Ph.D., J.D., is the President and CEO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Troy talks about his experiences being a CEO and the differences in responsibility between being a CEO and a board member. He also shares wha…

1
Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine 40:37

10M ago40:37

40:37

Synopsis: Keith Gottesdiener, MD, and Jeremy Duffield, MD, PhD, FRCP, are the President & CEO and CSO, respectively, of Prime Medicine. Prime Medicine was founded to bring the promise of gene editing to patients. They use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in …

1
Mehrnaz Campbell in conversation with Vanitha Venkatasbramaniam, Global Customer Engagement Strategy Lead, Novo Nordisk 54:44

10M ago54:44

54:44

I recently interviewed Vanitha Venkatasbramaniam, Global Digital Health and Customer Strategy Lead at Novo Nordisk, as part of our ongoing Digital Transformation Series. With over 15 years of experience in the pharma industry, Vanitha's mission revolves around making a positive impact on patients' lives with life-saving therapies. Vanitha currently…

1
Mehrnaz Campbell in conversation with Rick Hollis, Business & Customer Excellence Director, Ipsen UK & Ireland 47:57

10M ago47:57

47:57

I'm passionate about helping pharma field teams feel confident using technology to engage with HCPs. I want them to feel good about themselves and achieve amazing results. To explore this topic, I've been interviewing inspiring pharma leaders to learn from them as part of my Digital Transformation Series. Rick Hollis is the Business & Customer Exce…

1
Mehrnaz Campbell in conversation with Nataliya Andreychuk, CEO, Viseven 50:09

10M ago50:09

50:09

I have been inviting pharmaceutical leaders to learn from them and provide them with a platform to share their views as part of my Digital Transformation Series. Nataliya Andreychuk is the CEO of Viseven and a leading digital transformation evangelist for the pharmaceutical and life sciences industries. As a digital marketing professional with near…

1
Mehrnaz Campbell in conversation with Audrey Krassnitzer, Global MCE Director, Novo Nordisk 40:58

10M ago40:58

40:58

I was delighted to chat with Audrey Krassnitzer, Global MCE Director, Multichannel Engagement in Commercial Excellence at Novo Nordisk Rare Disease, as part of my Digital Transformation Series. Audrey is a Marketer, Storyteller, Strategist, and CX Enthusiast with 10+ years of experience in the pharma industry, strategic consulting, and marketing ag…

1
Mehrnaz Campbell in conversation with Rob Koster, Director - CX, Havas Health & You 30:20

10M ago30:20

30:20

I am passionate about helping pharma field professionals feel confident about using technology to improve the quality of their engagements with healthcare professionals. It's the human side of digital transformation that truly interests me, enabling people to leverage technology effectively. I am delighted to introduce Rob Koster, Director - CX at …

1
Mehrnaz Campbell in conversation with Dr Paul Tunnah, Managing Director, Healthware International 35:38

10M ago35:38

35:38

Dr Paul Tunnah has a passion for telling authentic stories and helping companies to co-create solutions to unlock the power of digital. He is also a man of many, many talents! Paul is the Chief Content Officer and Managing Director for Healthware International, a global health innovation and technology leader providing transformational advisory and…

1
Developing medicines for broad populations of cancer patients, Brett Hall, CSO, Immuneering 41:03

10M ago41:03

41:03

Synopsis: Brett Hall, Ph.D., is the CSO of Immuneering, a public, clinical-stage oncology company dedicated to developing medicines for broad populations of cancer patients by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. Brett talks about his background in the military targeting nuclear…

1
Mehrnaz Campbell in conversation with James Harper, Managing Director, twentyeightb 37:56

10M ago37:56

37:56

I recently had the pleasure to pick James' brain on a Linkedin Live, our first ever one! Which I have turned into this podcast. I thoroughly enjoyed hearing more about his career moves and opinions on the future of the field force. James Harper and I met through a Reuters webinar on omnichannel. Both of us were commenting about things we thought sh…

1
Mehrnaz Campbell in conversation with Sophie Graham-Godet, Global Director - Omnichannel Marketing Capabilities, GSK 21:16

10M ago21:16

21:16

I kickstarted 2023 by interviewing Sophie Graham-Godet from GSK as I continue my Digital Transformation Series. If you’ve listened to any of my previous podcasts or have been following me on LinkedIn, you will know that I'm incredibly passionate about helping pharma sales professionals get confident about using technology to improve the quality of …

1
Mehrnaz Campbell in conversation with Chris Wade, AVP of Strategic Solutions, Exeevo 30:13

10M ago30:13

30:13

When COVID-19 locked us down in 2020, the pharmaceutical industry rushed to buy digital tools so that their teams could continue to work remotely. What many organisations failed to do was help their teams transform and adopt omnichannel. Over the course of the year, I’ve been interviewing successful global pharma leaders about this topic and found …

1
Mehrnaz Campbell in conversation with Florent Edouard, SVP - Global Head of Commercial Excellence, Grünenthal 29:55

10M ago29:55

29:55

As part of my DIGITAL TRANSFORMATION SERIES, I thoroughly enjoyed talking to Florent Edouard about his diverse career and opinions on various industry topics! We related on so many topics and you can hear so many nuggets of golden information from him! A few of Florent’s points: To create a culture of innovation organisations need to stop micromana…

1
Mehrnaz Campbell in conversation with Paul Simms, Chief Executive, Impatient Health 30:11

10M ago30:11

30:11

For the next interview in our DIGITAL TRANSFORMATION SERIES, I enjoyed an entertaining chat with Paul Simms, Chief Executive of Impatient Health. Paul is a self-professed noisy introvert, and disruptive thinker, so you can tell this was going to be a little controversial. We discussed how looking at what other industries are doing is something the …

1
Mehrnaz Campbell in conversation with Frank Armenante, Director of Commercial Execution, Novo Nordisk 30:23

10M ago30:23

30:23

As part of our DIGITAL TRANSFORMATION SERIES, I am delighted to catch up with Frank Armenante, Director of Commercial Execution at Novo Nordisk. Novo Nordisk came out on top in a recent DT Consulting report on pharmaceutical companies' Customer Experience from the healthcare professional's perspective. I chatted with Frank about what they’re doing …

1
Mehrnaz Campbell in conversation with Koen Janssens and Kym Jacks-Bryant, Norgine 30:13

10M ago30:13

30:13

I recently chatted with Koen Janssens, Associate Director of Field Force Effectiveness at Norgine, and Kym Jacks-Bryant, Head of Digital Centre of Excellence at Norgine. As a company, Norgine has been leading the field in using technology for both healthcare professionals and patient engagement. They were also one of the first companies to invest i…

1
Mehrnaz Campbell in conversation with: Sebastien Noel, Director of Multichannel Strategy, Veeva Systems 26:25

10M ago26:25

26:25

In the second interview of the series, I chatted with Sebastien Noel. Sebastien is Director of Multichannel Strategy at Veeva Systems, with extensive experience in delivering SaaS solutions to the pharmaceutical industry. Mehrnaz and Sebastien Noel talk about how digital transformation has changed the pharmaceutical industry and how the technology …

Podcasts Worth a Listen

Daiichi Sankyo Podcasts

Podcasts Worth a Listen

Quick Reference Guide